<DOC>
	<DOCNO>NCT00819845</DOCNO>
	<brief_summary>Data preventive therapy Duchenne muscular dystrophy ( DMD ) Becker muscular dystrophy ( BMD ) affect individual without cardiac involvement limit currently lack regard ACE-inhibitors Beta-Blockers Becker Muscular Dystrophy latter even Duchenne Muscular Dystrophy patient . Thus , study aim compare efficacy carvedilol v ramipril myocardial tissue property heart function , perform CMR myocardial Ultrasound Tissue Characterisation analysis .</brief_summary>
	<brief_title>Ramipril Versus Carvedilol Duchenne Becker Patients</brief_title>
	<detailed_description>This protocol represent open randomize prospective trial , design answer specific question regard role cardioprotective therapy Duchenne Muscular Dystrophy Becker Muscular Dystrophy patient . In light , CMR could provide relevant data , reinforce scientific background , start early ( particularly BMD patient still debate question ) cardioprotective treatment carvedilol ramipril.Finally , clinical trial clarify whether preventive therapy may helpful clinical outcome , reduce myocardial fibrosis prevent progression towards cardiomyopathy .</detailed_description>
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy , Duchenne</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<criteria>1 . Immunohystochemical molecular diagnosis Duchenne Becker muscular dystrophy . 2 . Not evidence clinical cardiomyopathy , normal 2Dechocardiography normal systolic , WMSI = 1 ) diastolic function . 3 . DMD patient treat steroid therapy . 4 . All DMD BMD patient treat cardiological therapy ( ACEinhibitors , ARBs BetaBlockers ) . 5 . Written inform consent study participation ( serial visit , CMR echocardiographic study ) require patient , well parent guardian healthycontrol subject . 1 . Failure obtain informed consent patient , parent guardian . 2 . Any controindications carvedilol ramipril treatment ( bronchial asthma , diabetes , degree renal failure ( patient require normal creatinine level clearance ) . 3. BMD patient ECG change suggestive ischemic heart disease , leave bundlebranch block , atrial flutter/fibrillation , ventricular arrhythmia , degree atrioventricular block leave ventricular ( LV ) hypertrophy . Aspecific ST change consider electrocardiographic exclusion criterion DMD BMD patient . 4 . In BMD patient exclusion criterion also hypertension valvular heart disease trivial . 5 . DMD BMD patient require ventilatory ( noninvasive invasive ) assistance . 6 . Presence systolic and/or diastolic dysfunction detect 2DEchocardiography . 7 . Presence contraindication CMR ( include history claustrophobia ) . 8 . Patients age 2 year . 9 . Renal failure , even mild . 10 . Patient unable unwilling attend followup test , opinion local study principal investigator , ( child willing perform CMR enrol ) .</criteria>
	<gender>Male</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Duchenne</keyword>
	<keyword>Becker muscular dystrophy</keyword>
	<keyword>cardioprotective therapy</keyword>
	<keyword>cardiac magnetic resonance</keyword>
	<keyword>ultrasound tissue characterization</keyword>
</DOC>